{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSchlafen 11 (SLFN11) is emerging as a multifaceted DNA/RNA helicase that critically determines cancer cell response to a wide range of DNA‐damaging agents. High SLFN11 expression has been linked to an irreversibly stalled replication fork and increased chromatin accessibility at replication origins, resulting in enhanced cell death upon exposure to chemotherapeutics such as platinum compounds, topoisomerase inhibitors, and PARP inhibitors. In several malignancies—including small cell lung, ovarian, colorectal, prostate, and pediatric cancers—SLFN11 expression correlates with pronounced sensitivity to these drugs, whereas epigenetic silencing or promoter hypermethylation of the SLFN11 gene is associated with resistance. Moreover, oncogenic drives (for example, EWS–FLI1 in Ewing sarcoma) have been found to upregulate SLFN11, further potentiating this chemosensitive state."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n \n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the mechanistic level, SLFN11 is rapidly recruited to sites of replication stress where it interacts with proteins such as RPA1 and components of the replicative helicase. This recruitment does not impede the initiation of DNA replication but actively blocks the progression of replication forks by inducing local chromatin opening—a function that critically depends on its ATPase domain. In parallel, SLFN11 exerts a codon‐bias–dependent translational inhibition by binding specific transfer RNAs and cleaving them, selectively downregulating key checkpoint kinases like ATR and ATM. These combined actions amplify DNA damage signaling and abrogate homologous recombination repair, thereby intensifying cellular cytotoxicity in response to DNA‐damaging insults."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "18"}]}, {"type": "t", "text": "\n \n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in tumor cell chemosensitivity, SLFN11 functions as an antiviral restriction factor. By selectively inhibiting the translation of proteins encoded by codon-biased viral genomes, SLFN11 has been shown to abrogate the production of retroviruses such as HIV‐1 and to restrict the replication of several flaviviruses, including West Nile, dengue, and Zika viruses. Recent evidence also suggests that SLFN11 can act as a sensor for intracellular single‐stranded DNA, triggering innate immune responses through targeted tRNA cleavage that promotes cytokine production and cell death."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "19", "end_ref": "21"}]}, {"type": "t", "text": "\n \n"}, {"type": "p", "children": [{"type": "t", "text": "\nSLFN11 activity is tightly regulated by both epigenetic and post‐translational modifications. DNA methylation of its promoter frequently underlies its silencing in various tumor types, while dynamic phosphorylation regulates its activation state via protein phosphatases. Beyond its direct role in DNA damage responses, SLFN11 also modulates additional signaling cascades—for instance, through physical association with proteins such as RPS4X to suppress mTOR signaling in hepatocellular carcinoma—and its expression in circulating tumor cells serves as a promising noninvasive biomarker for patient stratification. Furthermore, in noncancer contexts such as Fanconi anemia and germinal center B-cell development, proper regulation of SLFN11 is essential to balance replication fork stabilization and genome integrity. Collectively, these studies underscore SLFN11’s dual utility as both a mechanistic effector of replicative stress and an important prognostic biomarker for precision oncology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "22", "end_ref": "30"}]}, {"type": "t", "text": ""}]}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Eric E Gardner, Benjamin H Lok, Valentina E Schneeberger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccell.2017.01.006"}], "href": "https://doi.org/10.1016/j.ccell.2017.01.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28196596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28196596"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Gabriele Zoppoli, Marie Regairaz, Elisabetta Leo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1205943109"}], "href": "https://doi.org/10.1073/pnas.1205943109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22927417"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22927417"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Junko Murai, Sai-Wen Tang, Elisabetta Leo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLFN11 Blocks Stressed Replication Forks Independently of ATR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2018.01.012"}], "href": "https://doi.org/10.1016/j.molcel.2018.01.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29395061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29395061"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Vanesa Nogales, William C Reinhold, Sudhir Varma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6413"}], "href": "https://doi.org/10.18632/oncotarget.6413"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26625211"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26625211"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yanhua Mu, Jiangman Lou, Mrinal Srivastava, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLFN11 inhibits checkpoint maintenance and homologous recombination repair."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embr.201540964"}], "href": "https://doi.org/10.15252/embr.201540964"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26658330"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26658330"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Florence Coussy, Rania El-Botty, Sophie Château-Joubert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Transl Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scitranslmed.aax2625"}], "href": "https://doi.org/10.1126/scitranslmed.aax2625"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32075943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32075943"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Sai-Wen Tang, Sven Bilke, Liang Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-14-2112"}], "href": "https://doi.org/10.1158/1078-0432.CCR-14-2112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25779942"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25779942"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Vincenza Conteduca, Sheng-Yu Ku, Loredana Puca, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-19-0926"}], "href": "https://doi.org/10.1158/1535-7163.MCT-19-0926"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32127465"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32127465"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Tao He, Meiying Zhang, Ruipan Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenomics (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/epi-2017-0019"}], "href": "https://doi.org/10.2217/epi-2017-0019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28403629"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28403629"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Junko Murai, Hongliang Zhang, Lorinc Pongor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chromatin Remodeling and Immediate Early Gene Activation by SLFN11 in Response to Replication Stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2020.02.117"}], "href": "https://doi.org/10.1016/j.celrep.2020.02.117"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32209474"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32209474"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yan-Ping Yin, Li-Ying Ma, Guo-Zhen Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FK228 potentiates topotecan activity against small cell lung cancer cells via induction of SLFN11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Pharmacol Sin (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41401-021-00817-y"}], "href": "https://doi.org/10.1038/s41401-021-00817-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34893686"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34893686"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jessica Gartrell, Marcia Mellado-Largarde, Michael R Clay, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-21-0089"}], "href": "https://doi.org/10.1158/1535-7163.MCT-21-0089"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34413129"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34413129"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "He-Xi Wang, Zhi-Peng Zhao, Xiao-Yi Du, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-023-02262-9"}], "href": "https://doi.org/10.1007/s12032-023-02262-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38206539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38206539"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Bingnan Zhang, C Allison Stewart, Qi Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41416-022-01811-9"}], "href": "https://doi.org/10.1038/s41416-022-01811-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35440668"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35440668"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Manqing Li, Elaine Kao, Xia Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature11433"}], "href": "https://doi.org/10.1038/nature11433"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23000900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23000900"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Manqing Li, Elaine Kao, Dane Malone, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41594-018-0142-5"}], "href": "https://doi.org/10.1038/s41594-018-0142-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30374083"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30374083"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Dane Malone, Rea M Lardelli, Manqing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dephosphorylation activates the interferon-stimulated Schlafen family member 11 in the DNA damage response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.006588"}], "href": "https://doi.org/10.1074/jbc.RA118.006588"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31395656"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31395656"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Felix J Metzner, Simon J Wenzl, Michael Kugler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanistic understanding of human SLFN11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-022-33123-0"}], "href": "https://doi.org/10.1038/s41467-022-33123-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36115853"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36115853"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Federico Valdez, Julienne Salvador, Pedro M Palermo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Schlafen 11 Restricts Flavivirus Replication."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.00104-19"}], "href": "https://doi.org/10.1128/JVI.00104-19"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31118262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31118262"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Lingzhen Dai, Amar Mehta, Irina Mordukhovich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential DNA methylation and PM"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2.5"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " species in a 450K epigenome-wide association study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenetics (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15592294.2016.1271853"}], "href": "https://doi.org/10.1080/15592294.2016.1271853"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27982729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27982729"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Peng Zhang, Xiaoqing Hu, Zekun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Schlafen 11 triggers innate immune responses through its ribonuclease activity upon detection of single-stranded DNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Immunol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/sciimmunol.adj5465"}], "href": "https://doi.org/10.1126/sciimmunol.adj5465"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38875319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38875319"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Yanhong Deng, Yue Cai, Yan Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-015-1840-6"}], "href": "https://doi.org/10.1186/s12885-015-1840-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26525741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26525741"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Kevin Shee, Jason D Wells, Amanda Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0224267"}], "href": "https://doi.org/10.1371/journal.pone.0224267"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31682620"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31682620"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Tsuyoshi Takashima, Naoya Sakamoto, Junko Murai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virchows Arch (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00428-020-02840-6"}], "href": "https://doi.org/10.1007/s00428-020-02840-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32474729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32474729"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Tsuyoshi Takashima, Daiki Taniyama, Naoya Sakamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41416-021-01364-3"}], "href": "https://doi.org/10.1038/s41416-021-01364-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33785877"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33785877"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Yusuke Okamoto, Masako Abe, Anfeng Mu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLFN11 promotes stalled fork degradation that underlies the phenotype in Fanconi anemia cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood.2019003782"}], "href": "https://doi.org/10.1182/blood.2019003782"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32735670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32735670"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Fumiya Moribe, Momoko Nishikori, Tsuyoshi Takashima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0237554"}], "href": "https://doi.org/10.1371/journal.pone.0237554"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33513156"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33513156"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Katie Nightingale, Martin Potts, Leah M Hunter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.2108173119"}], "href": "https://doi.org/10.1073/pnas.2108173119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35105802"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35105802"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Mariafausta Fischietti, Frank Eckerdt, Ricardo E Perez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res Commun (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2767-9764.crc-22-0192"}], "href": "https://doi.org/10.1158/2767-9764.crc-22-0192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36382088"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36382088"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Erin Alvi, Ayako L Mochizuki, Yoko Katsuki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mouse Slfn8 and Slfn9 genes complement human cells lacking SLFN11 during the replication stress response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Commun Biol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s42003-023-05406-9"}], "href": "https://doi.org/10.1038/s42003-023-05406-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37833372"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37833372"}]}]}]}